Abstract
Streptococcus pneumoniae produces the pore-forming toxin pneumolysin (PLY), which is a member of the cholesterol-dependent cytolysin (CDC) family of toxins. The CDCs recognize and bind the 3β-hydroxyl group of cholesterol at the cell surface, which initiates membrane pore formation. The cholesterol transport lipoproteins, which carry cholesterol in their outer monolayer, are potential off-pathway binding targets for the CDCs and are present at significant levels in the serum and the interstitial spaces of cells. Herein we show that cholesterol carried specifically by the ApoB-100-containing lipoprotein particles (CH-ApoB-100) in the mouse, but not that carried by human or guinea pig particles, is a potent inhibitor of the PLY pore-forming mechanism. Cholesterol present in the outer monolayer of mouse ApoB-100 particles is recognized and bound by PLY, which stimulates premature assembly of the PLY oligomeric complex thereby inactivating PLY. These studies further suggest that the vast difference in the inhibitory capacity of mouse CH-ApoB-100 and that of the human and the guinea pig is due to differences in the presentation of cholesterol in the outer monolayer of their ApoB-100 particles. Therefore mouse CH-ApoB-100 represents a significant innate CDC inhibitor that is absent in humans, which may underestimate the contribution of CDCs to human disease when utilizing mouse models of disease.
Highlights
A major component of the mammalian cellular membrane is cholesterol, which is transported to and from cells via lipoprotein cholesterol carriers [1,2]
The pore-forming cholesterol-dependent cytolysins (CDCs) are one of the most widely disseminated virulence factors expressed by Gram-positive pathogens
PLY and most CDCs bind cholesterol as their cellular receptor, which initiates the formation of the oligomeric pore complex
Summary
A major component of the mammalian cellular membrane is cholesterol, which is transported to and from cells via lipoprotein cholesterol carriers [1,2]. Cholesterol binding is mediated via a strictly conserved Thr-Leu cholesterol-recognition motif (CRM) in domain 4 of the CDC structure [4]. The CRM recognizes the cholesterol 3b-hydroxyl group: modifications to this group render cholesterol inert to CDC recognition [5,6]. Cholesterol binding initiates the formation of the CDC oligomeric pore complex [7]. In addition to cellular membranes, cholesterol is located in the outer lipid monolayer shell and core of lipoprotein particles (Figure 1), which are found in abundance in the serum, lymph and interstitial spaces. The cholesterol carried by these particles represents a potential offpathway target for the CDCs, which could lead to their inactivation
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
